These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1355583)

  • 21. [Editor's commentary: Clinical use of somatostatin].
    Tulassay Z
    Orv Hetil; 2013 Sep; 154(39):1526. PubMed ID: 24058096
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatostatin--a new hypothalamo-enteral hormone.
    Raptis S; Dollinger HC
    Z Gastroenterol Verh; 1976; (10):32-42. PubMed ID: 64050
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pituitary gland and mammary growth hormone in the dog].
    Bhatti SF
    Tijdschr Diergeneeskd; 2007 May; 132(10):390-2. PubMed ID: 17578229
    [No Abstract]   [Full Text] [Related]  

  • 24. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.
    Qin Y; Ertl T; Groot K; Horvath J; Cai RZ; Schally AV
    Int J Cancer; 1995 Mar; 60(5):694-700. PubMed ID: 7860145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995).
    Weckbecker G; Tolcsvai L; Liu R; Bruns C
    Metabolism; 1992 Sep; 41(9 Suppl 2):99-103. PubMed ID: 1325597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
    Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases].
    Consolo F; Pustorino S
    Minerva Chir; 1992 Apr; 47(8):723-9. PubMed ID: 1351277
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in the formulation and delivery of somatostatin analogs for acromegaly.
    Fattah S; Brayden DJ
    Ther Deliv; 2017 Oct; 8(10):867-878. PubMed ID: 28944744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis.
    Murray RD; Kim K; Ren SG; Chelly M; Umehara Y; Melmed S
    J Clin Invest; 2004 Aug; 114(3):349-56. PubMed ID: 15286801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs.
    Matrone C; Pivonello R; Colao A; Cappabianca P; Cavallo LM; Del Basso De Caro ML; Taylor JE; Culler MD; Lombardi G; Di Renzo GF; Annunziato L
    Neuroendocrinology; 2004 Mar; 79(3):142-8. PubMed ID: 15103227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrally applied somatostatin inhibits the estrogen-induced luteinizing hormone surge via hypothalamic gonadotropin-releasing hormone cell activation in female rats.
    Van Vugt HH; Swarts HJ; Van de Heijning BJ; Van der Beek EM
    Biol Reprod; 2004 Sep; 71(3):813-9. PubMed ID: 15140796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
    Liebow C; Reilly C; Serrano M; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide.
    van Eijck CH; Slooter GD; Hofland LJ; Kort W; Jeekel J; Lamberts SW; Marquet RL
    Br J Surg; 1994 Sep; 81(9):1333-7. PubMed ID: 7953404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.
    Cives M; Strosberg J
    Drugs; 2015 May; 75(8):847-58. PubMed ID: 25911185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide.
    Hajri A; Bruns C; Marbach P; Aprahamian M; Longnecker DS; Damgé C
    Eur J Cancer; 1991; 27(10):1247-52. PubMed ID: 1683556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.
    Walter T; Hommell-Fontaine J; Gouysse G; Pourreyron C; Nejjari M; Villaume K; Causeret S; Hervieu V; Poncet G; Roche C; Scoazec JY
    Neuroendocrinology; 2011; 94(3):200-8. PubMed ID: 21677423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.